Hosted on MSN1mon
First Drug Approved for Familial Chylomicronemia SyndromeA first-in-class antisense oligonucleotide ... Olezarsen is an mRNA-targeted ligand conjugated antisense medicine that works by lowering the body's production of apolipoprotein C-III, a key ...
Sanofi has entered into a collaboration and license agreement with Alloy Therapeutics to develop an antisense oligonucleotide ... field include Biogen’s ASO Spinraza (nusinersen) approved ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback